Continue reading this on our app for a better experience

Open in App
Floating Button
Home Capital Broker's Calls

Analysts optimistic on AEM as it expands to take advantage of industry uptrend

Lim Hui Jie
Lim Hui Jie • 3 min read
Analysts optimistic on AEM as it expands to take advantage of industry uptrend
With Intel announcing an expansion in Malaysia in Dec 2021, analysts are optimistic on its key test provider, AEM.
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Analysts from CGS-CIMB, DBS Group Research and Maybank have maintained their “buy” calls on AEM Holdings, following the company’s latest FY2022 revenue guidance of $670 million to $720 million.

In his Jan 10 report, CGS-CIMB analyst William Tng notes that AEM will benefit from its key customer Intel’s hefty expansion in Malaysia, driving AEM’s FY2023 earnings to a record.

As such, Tng has raised his target price to $7.90 from $5.84, to factor in a 10.7% to 12.2% increase in his FY2022 and FY2023 earnings estimates.

Intel’s capacity expansion will cost US$7.1 billion, according to Malaysia’s Ministry of International Trade and Industry on Dec 16 2021.

Intel already has a significant presence in Malaysia, particularly the state of Penang.

“In our view, Intel’s expansion plan in Penang is a positive for AEM,” writes Tng.

See also: AEM guides for FY2022 revenue to range from $670 mil to $720 mil

“With production slated for early 2024, we believe order momentum for AEM’s test handlers will be robust in FY2022 - 2023,” he adds.

Some catalysts for AEM, Tng observes, are stronger-than-expected orders from its major customer and earlier-than-expected success in securing orders from other prospective customers.

On the other hand, downside risks are cost pressures as well as delivery delays with supply chain woes continuing. Intel itself is facing more competition and AEM investors should take that into consideration.

See also: Test debug host entity

DBS analyst Chung Wei Le maintains his target price of $6.04, and also notes that AEM’s share price has a strong positive correlation with the US semiconductor equipment billings, which is one of the indicators of the industry’s strength.

“Despite 25 consecutive monthly (y-o-y) increases, preliminary estimates for October indicate a 41.3% y-o-y rise. We believe AEM is in a strategic position to benefit from its key customer and industry uptrend, and could re-rate higher,” Chung points out.

Chung, citing Intel, notes that the semiconductor industry could double to US$1 trillion by 2030.

Intel is also ready to commit significant investments to ensure that it is at the forefront, and Chung believes that this will translate into higher revenues for AEM in FY2022-2023.

However, he does also caution on concentration risk, saying around 95% of AEM’s revenue is derived from Intel.

In a typical year, about 50% of the revenue is from the sales of equipment, which is lumpy in nature and dependent on Intel’s need to replace existing machines or increase its production capacity.

As for Maybank’s Lai Gene Lih, he also broadly agrees with the points above, maintaining his target price of $6.23 for AEM.

For more stories about where money flows, click here for Capital Section

He points out, however, that there’s “room for positive guidance revisions” in FY2022. “AEM has historically been conservative in guidance – especially at the start of the year. We expect positive guidance revisions throughout the year,” Lai adds.

He expects demand for the AEM’s new generation equipment to be underpinned by Intel’s new generation data centre and client products, namely Sapphire Rapids and Alder Lake.

These are Intel’s first mass produced heterogeneously packaged chips, which he believes require greater reliance on system-level tests.

Lai also thinks that Intel’s planned US$7 billion spending in Penang over 10 years is positive, and not factored in the guidance, as the new facility only broke ground in Dec 2021.

At 11.17am, AEM traded at $5.11, with a FY2021 price to book ratio of 3.92 and dividend yield of 1.4%, according to CGS-CIMB.

Highlights

Re test Testing QA Spotlight
1000th issue

Re test Testing QA Spotlight

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2024 The Edge Publishing Pte Ltd. All rights reserved.